Meg Bregazzi

Meg Bregazzi is a seasoned professional in the life sciences and investment sectors. As a Partner and Co-Founder at Adara Venture Capital since January 2022, Meg focuses on impactful investments in life sciences. Currently serving as a Board Member for Zymedyne Therapeutics and the Alberta Children's Hospital Foundation, Meg chairs the Finance & Audit Committee for the Foundation. In addition, Meg holds the role of Investment Advisor for UCeed Health, Neuro and Child Health Funds at Innovate Calgary and serves as President of Tredea Capital Corp. with extensive prior experience, including positions such as Treasurer & Co-Founder at Canarbour Investment Limited Partnership and VP Finance at Channel Investment Fund. Meg's educational background includes a BSc in Medical Laboratory Science from the University of Alberta, Chartered Accountant prerequisites from the University of Calgary, and ongoing studies in the ICD-Rotman Directors Education Program at the University of Toronto.